• 검색 결과가 없습니다.

Peginterferon alpha and ribavirin combination therapy in patients with hepatitis C virus-related liver cirrhosis

N/A
N/A
Protected

Academic year: 2021

Share "Peginterferon alpha and ribavirin combination therapy in patients with hepatitis C virus-related liver cirrhosis"

Copied!
6
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

수치

Table 1. Baseline characteristics of patients according to HCV genotype
Figure 2. End of treatment response (ETR) and SVR rates  according to HCV genotypes. ETR and SVR rates were  significantly higher in patients with genotype non-1 than in those  with genotype 1 (71.1% vs
Table 4. Frequencies of adverse events (N=86)

참조

관련 문서

1 John Owen, Justification by Faith Alone, in The Works of John Owen, ed. John Bolt, trans. Scott Clark, "Do This and Live: Christ's Active Obedience as the

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind,

Purpose: This study was designed to evaluate the clinical characteristics and the treatment of colonoscopic perforation and the availability of

The aim of this study was to provide a optimal drug therapy which secures effectiveness and safeness in elderly patients by analyzing polypharmacy and the

In this study, to investigate how applying a critical pathway to stomach cancer patients affects their recovery and treatment, the clinical effect of the critical

Full genome cloning and nucleotide sequence analysis of hepatitis C virus from sera of chronic hepatitis patients in Korea. Detection of hepatitis C virus RNA

The purpose of this study was to identify the frequency and related factors of advanced airway management for patients with cardiac arrest by the

The purpose of this study was to provide primary material in discussing methods to activate the treatment effects of diabetes and reduce the rate of